INSIGHT MOLECULAR DIAGNOSTIC (IMDX:NASDAQ)
$5.32 -0.38 (-6.6667%)
Analysed INSIGHT MOLECULAR DIAGNOSTIC (IMDX:NASDAQ) News Sources
Why The Insight Molecular Diagnostics (IMDX) Story Is Shifting After Cash Raise And FDA Catalyst
13-04-2026
yahoo.com
Real-World Evidence and Industry Momentum Builds for iMDx’s Flagship GraftAssure Assay
14-04-2026
yahoo.com
How The Insight Molecular Diagnostics (IMDX) Story Is Shifting With Funding And GraftAssureDx Milestones
29-04-2026
yahoo.com
iMDx to Release First Quarter 2026 Results on May 13, 2026
06-05-2026
yahoo.com
IMDX Reports Q1 2026 Results and Update on Progress Toward GraftAssure Commercialization
13-05-2026
yahoo.com
Insight Molecular Diagnostics Inc (IMDX) Q1 2026 Earnings Call Highlights: Strategic Advances ...
14-05-2026
yahoo.com
How Insight Molecular Diagnostics (IMDX) Story Is Shifting With Fresh Capital And GraftAssureDx Submission
15-05-2026
yahoo.com
iMDx to Highlight In-House Transplant Testing Opportunity and Host Key Opinion Leaders at American Transplant Congress
09-06-2026
yahoo.com
IMDX GraftAssure Assay Sets New Standard in Screening Kidney Transplant Patients Per American Journal of Transplantation
11-06-2026
yahoo.com
Favorable Head-to-Head Data on iMDx’s GraftAssure with Competing NGS Assay Published in Clinical Chemistry
16-06-2026
yahoo.com
What is the current price of INSIGHT MOLECULAR DIAGNOSTIC (IMDX:NASDAQ)?
The current price of INSIGHT MOLECULAR DIAGNOSTIC (IMDX:NASDAQ) is $5.32.
INSIGHT MOLECULAR DIAGNOSTIC (IMDX:NASDAQ) absolute price change since previous trading day?
The absolute price change of INSIGHT MOLECULAR DIAGNOSTIC (IMDX:NASDAQ) since the previous trading day is $-0.38.
INSIGHT MOLECULAR DIAGNOSTIC (IMDX:NASDAQ) percentage price change since previous trading day?
The percentage price change of INSIGHT MOLECULAR DIAGNOSTIC (IMDX:NASDAQ) since the previous trading day is -6.6667%.
What is the most recent average sentiment score for INSIGHT MOLECULAR DIAGNOSTIC (IMDX:NASDAQ)?
The most recent average sentiment score for INSIGHT MOLECULAR DIAGNOSTIC (IMDX:NASDAQ) is 68 out of 100.
What is the most recent average sentiment for INSIGHT MOLECULAR DIAGNOSTIC (IMDX:NASDAQ)?
The most recent sentiment for INSIGHT MOLECULAR DIAGNOSTIC (IMDX:NASDAQ) is .
SEC-8K** Filing Available For INSIGHT MOLECULAR DIAGNOSTIC (IMDX:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.